0000950172-24-000233.txt : 20240425
0000950172-24-000233.hdr.sgml : 20240425
20240425103514
ACCESSION NUMBER: 0000950172-24-000233
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240424
FILED AS OF DATE: 20240425
DATE AS OF CHANGE: 20240425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glickman Richard M
CENTRAL INDEX KEY: 0001352637
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37410
FILM NUMBER: 24873615
MAIL ADDRESS:
STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION
STREET 2: 1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: V8Z7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ESSA Pharma Inc.
CENTRAL INDEX KEY: 0001633932
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: SUITE 720
STREET 2: 999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
BUSINESS PHONE: (778) 331-0962
MAIL ADDRESS:
STREET 1: SUITE 720
STREET 2: 999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
4
1
form4.xml
X0508
4
2024-04-24
0001633932
ESSA Pharma Inc.
EPIX
0001352637
Glickman Richard M
C/O ESSA PHARMA INC.
999 WEST BROADWAY, SUITE 720
VANCOUVER
A1
V5Z 1K5
BRITISH COLUMBIA, CANADA
true
false
Common Shares
2024-04-24
4
M
0
3750
4.9
A
43240
D
Options
4.9
2024-04-24
4
M
0
3750
0
D
2022-03-21
2024-05-21
Common Shares
3750
0
D
/s/ Richard Glickman
2024-04-25